ArticleThe oncologist2021

BRAF V600E Mediates Crizotinib Resistance and Responds to Dabrafenib and Trametinib in a ROS1-Rearranged Non-Small Cell Lung Cancer: A Case Report.

Juan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.